Lv2
160 积分 2022-08-17 加入
Induction chemotherapy and molecular MRD influence outcomes in KMT2A -rearranged AML
4天前
已关闭
A Relapsing Meningeal Acute Myeloid Leukaemia FLT3-ITD+ Responding to Gilteritinib
1个月前
已完结
Olverembatinib in accelerated-phase chronic myeloid leukemia: efficacy and safety evaluation
5个月前
已完结
Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia
6个月前
已完结
Microenvironment and drug resistance in acute myeloid leukemia: Do we know enough?
7个月前
已完结
How I use Maintenance Therapy in Acute Myeloid Leukemia
7个月前
已完结
TP53-Mutated Acute Myeloid Leukemia: How Can We Improve Outcomes?
7个月前
已完结
Novel Treatment Strategies for Chronic Myeloid Leukemia
8个月前
已完结
Chronic Myeloid Leukemia in Renal Transplantation Patients in the Era of Tyrosine Kinase Inhibitors: A Case Report and Review of the Literature
8个月前
已完结
Structural and clinical consequences of activation loop mutations in class III receptor tyrosine kinases
8个月前
已完结
皖公网安备34019202002308
